Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario

Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario

Childhood cancer is considered rare, corresponding to ~3% of all malignant neoplasms in the human population. The World Health Organization (WHO) reports a universal occurrence of more than 15 cases per 100,000 inhabitants around the globe, and despite improvements in diagnosis, treatment and suppor...

Full description

Bibliographic Details
Main Authors: Marina Ferreira Candido, Mariana Medeiros, Luciana Chain Veronez, David Bastos, Karla Laissa Oliveira, Julia Alejandra Pezuk, Elvis Terci Valera, María Sol Brassesco
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Pharmaceutics
Subjects:
childhood cancer
kinases
chemical inhibitors
clinical trials
Online Access:https://www.mdpi.com/1999-4923/15/2/664

Internet

https://www.mdpi.com/1999-4923/15/2/664

Similar Items